Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001693796 | SCV001914666 | benign | not provided | 2019-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001788799 | SCV002029645 | benign | Galloway-Mowat syndrome 7 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001788798 | SCV002029656 | benign | Nephrotic syndrome, type 11 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001693796 | SCV002433711 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594528 | SCV005087819 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 34% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 32. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001693796 | SCV005231295 | benign | not provided | criteria provided, single submitter | not provided |